Search for other papers by Richard T. Katz in
Current site
Google Scholar
PubMed
Search for other papers by Robert B. Katz in
Current site
Google Scholar
PubMed
Abstract
In the interface between medicine and law, physicians may be asked to comment on a patient's life expectancy. Life expectancy is based on life tables, eg, from the US census, and are published in National Vital Statistics reports. The life expectancy for a particular patient with a serious medical illness or disability cannot be determined from such tables; rather one must investigate the life expectancies associated with the patient's particular disease or condition. Standardized mortality ratios have a complex relationship to life expectancy, depending on the patient's age and specific conditions. For example, excellent data are available regarding life expectancy for individuals with spinal cord injury (SCI) and are sorted in various ways, eg conditional life expectancy calculated for persons who have survived the first year after an SCI. Major depressive disorder is associated with increased mortality due to suicidality and other causes (eg, cardiovascular disease or respiratory disease); men with mental disorders live twenty years less and women live fifteen years less compared with the general population. To testify about life expectancy in a person with neurological or psychiatric disability, the experience of a personal physician is not adequate—familiarity with epidemiological data is a prerequisite. This article is based on a wide and recent body of literature concerning life expectancy and gives an indication of some of the complexities regarding life expectancy.
- Abstract
- Primer on Life Expectancy Determination
- Life expectancy in Various neurological conditions
- Cerebral Palsy
- Developmental Disability
- Spinal Cord Injury
- Traumatic and Hypoxic Brain Injury
- Persistent Vegetative State
- Locked-in Syndrome
- Seizures
- Life expectancy in several psychiatric conditions
- Depression, Bipolar, and Anxiety Disorders
- Anxiety Disorders
- Schizophrenia
- Attention Deficit Hyperactivity Disorder
- Alcohol
- Illicit Drug Use
- Personality Disorder
- SUMMARY
- References
-
1.
Katz RT. Life care plans. Guides Newsletter. September–October 2016.
-
2.
Vachon PJ, Sestier F. Life expectancy determination. Phys Med Rehabil Clin N Am. 2013; 24:539–551.
-
3.
Westbom L, Bergstrand L, Wagner P, et al. Survival at 19 years of age in a total population of children and young people with CP. Developmental Medicine and Child Neurology. 2011; 53:808–814.
-
4.
Reid SM, Carlin JB, Reddihough D. Survival of individuals with cerebral palsy born in Victoria, Australia, between 1970 and 2004. Dev Med Child Neurol. 2012; 54:353–360.
-
5.
Brooks JC, Shavelle RM, Strauss DJ. Survival in children with severe cerebral palsy: further international comparison (letter). Dev Med Child Neurol. 2012; 54:383–384.
-
6.
Touyama DM, Touyama J, Ochiai Y, et al. Long-term survival of children with cerebral palsy in Okinawa, Japan. Dev Med Child Neurol. 2013; 55:459–463.
-
7.
Colver A, Fairhurst C, Pharoah POD. Cerebral palsy. Lancet. 2014; 383:1240–1249.
-
8.
Brooks JC, Strauss DJ, Shavelle RM, et al. Recent trends in cerebral palsy survival. Part I: period and cohort effects. Dev Med Child Neurol. 2014a; 56:1059–1064.
-
9a.
Brooks JC, Strauss DJ, Shavelle RM, et al (2014b). Recent trends in cerebral palsy survival. Part II: individual survival prognosis. Dev Med Child Neurol. 2014b; 56:1065–1071.
-
9b.
Brooks JC, Shavelle RM, Strauss DJ, et al. Long-term survival after TBI. Part I: external validity of prognostic models. Arch Phys Med Rehabil. 2015a; 96:994–999.
-
9c.
Brooks JC, Shavelle RM, Strauss DJ, et al. Long-term survival after TBI. Part II: life expectancy. Arch Phys Med Rehabil. 2015b; 96:1000–1005.
-
10.
Himmelman K, Sundh V. Survival with cerebral palsy over five decades in western Sweden. Dev Med Child Neurol. doi: 10.1111/dmcn.12718, 2015.
-
11.
Tyrer F, Smith LK, McGrother CW. Mortality in adults with moderate to profound intellectual disability. J Intellect Disab Res. 2007; 51:520–527.
-
12.
Tyrer F, McGrother C. Cause specific mortality and death certificate reporting in adults with moderate to profound intellectual disability. J Intellect Disab Res. 2009; 53:898–994.
-
13.
Kiani R, Tyrer F, Jesu A, et al. Mortality from sudden unexpected death in epilepsy in a cohort of adults with intellectual disability. J Intellect Disabil Res. doi: 10.1111/jir.12047.
-
14.
Heslop P, Blair PS, Fleming P, et al. Confidential inquiry into premature deaths of people with intellectual disability in the UK: population based study. Lancet. 2014; 383:889–895.
-
15.
Heslop P, Glover G. Mortality of people with intellectual disabilities in England: a comparison of data from existing sources. J Appl Res Intellect Disabil. 2015; 28:414–422.
-
16.
Florio T, Trollor J. Mortality among a cohort of persons with an intellectual disability in New South Wales, Australia. J Appl Res Intellect Disabil. 2015; 28:383–393.
-
17.
Savic G, DeVivo MJ, Frankel HL. Long-term survival after traumatic SCI. Spinal Cord. 2017; 55:651–658.
-
18.
Brooks JC, Strauss DJ, Shavelle RM, et al. Long-term disability and survival in TBI. Arch Phys Med Rehabil. 2013; 94:2203–2209.
-
19.
Shavelle R, Brooks J, Strauss D, et al. Note on survival after anoxic brain injury in adolescents and young adults. Neuro Rehabil. 2015; 36:379–382.
-
20.
Multi-Society Task Force on the Persistent Vegetative State. Medical aspects of the persistent vegetative state. NEJM. 1994; 330:1499–1508.
-
21.
Multi-Society Task Force on the Persistent Vegetative State. Medical aspects of the persistent vegetative state. NEJM. 1994; 330:1572–1579.
-
22.
Pagani M, Leonardi M, Covelli V, et al. Risk factors for mortality in 600 patients in vegetative and minimally conscious states. J Neurol. 2014; 261:1144–1152.
-
23.
Katz RT, Haig AJ, Clark BB, DiPaola R. Long-term survival, prognosis, and life-care planning for 29 patients with chronic locked-in syndrome. Archives of Physical Medicine and Rehabilitation. 1992; 73:403–408.
-
24.
Doble JE, Haig AJ, Anderson C, Katz RT. Impairment, activity, participation, life satisfaction and survival in persons with locked-in syndrome for over a decade. Journal of Head Trauma Rehabilitation. 2003; 18:435–444.
-
25.
Forsgren L, Hauser WA, Olafsson E, et al. Mortality of epilepsy in developed countries: a review. Epilepsia. 2005; 11:18–27.
-
26.
Sillanpaa M, Shinnar S. Long-term mortality in childhood-onset epilepsy. NEJM. 2010; 363:2522–2529.
-
27.
Neligan A, Bell G, Johnson AL, et al. Long-term risk of premature mortality in people with epilepsy. Brain. 2011; 134:388–395.
-
28.
Neligan A, Bell GS, Shorvon SD, et al. Temporal trends in the mortality of people with epilepsy: a review. Epilepsia. 2010; 51:2241–2246.
-
29.
Gaitatzis A, Johnson AL, Chadwick DW, et al. Life expectancy in people with newly diagnosed epilepsy. Brain. 2004; 127:2427–2432.
-
30.
Fazel S, Wolf A, Langstrom N, et al. Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study. Lancet. 2013; 382:1646–1654.
-
31.
Tomson T, Nashef L, Ryvlin P. Sudden unexpected death in epilepsy. Lancet (Neurology). 2008; 7:1021–1031.
-
32.
Opeskin K, Berkovic SF. Risk factors in sudden unexpected death in epilepsy. Seizure. 2003; 12:456–464.
-
33.
Nilsson L, Farahmand BY, Persson P, et al. Risk factors for sudden unexpected death in epilepsy. Lancet. 1999; 353:888–893.
-
34.
Berg AT, Nickels K, Wirrell EC, et al. Mortality risks in new onset childhood epilepsy. Pediatrics. 2013; 132:124–131.
-
35.
Alcantara C, Muntner P, Edmondson D, et al. The perfect storm: concurrent stress and depressive symptoms increase risk of MI or death. Circ Cardiovasc Qual Outcomes. 2015; 8:146–154.
-
36.
Angst F, Stassen HH, Clayton PJ, et al. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002; 68:167–181.
-
37.
Hiroeh U, Appleby L, Mortensen PB, et al. Death by homicide, suicide, and other unnatural causes in people with mental illness: a population-based study. Lancet. 2001; 358:2110–2012.
-
38.
Gilsanz P, Walter S, Tchetgen EJ, et al. Changes in depressive symptoms and incidence of first stroke among middle-aged and older US adults. J Am Heart Assoc. 2015; 4(5).
-
39.
Bergen H, Hawton K, Waters K. Premature death after self-harm: multicenter cohort study. Lancet. dx.doi.org/10.1016/S0140-6736(12)61509-8.
-
40.
Wahlbeck K, Westman J, Nordentoft M, et al. Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry. 2011; 199:453–458.
-
41.
Crump C, Sundquist K, Winkleby MA, et al. Comorbidities and mortality in bipolar disorder. JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2013.1394.
-
42.
Reislinger-Walker E, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications. JAMA Psychiatry. doi: 10.1001/jamapsychiatry.2014.2502.
-
43.
Elias M. Mentally ill die 25 years earlier, on average. USA Today. May 3, 2007.
-
44.
Parks J, Svendsen D, Singer P, et al. Morbidity and mortality in people with serious mental illness. National Association of State Mental Health Program Directors Medical Directors Council. http://www.nasmhpd.org/general_files/publications/med_directors_pubs/Technical%20Report%20on%20Morbidity%20and%20Mortality%20-%20Final%2011-06.pdf.
-
45.
Tiihonen J, Lonnqvist J, Wahlbeck K, et al. Eleven year follow up of mortality in patients with schizophrenia: population-based cohort study. Lancet. 2009; 374:620–627.
-
46.
Nielsen SF, Hjortoj CR, Erlangsten A, et al. Psychiatric disorders and mortality among people in homeless shelters in Denmark: nationwide register-based cohort study. Lancet. 2011; 377:2205–2214.
-
47.
Lawrence D, Hancock KJ, Kisely S. Gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ. doi: 10.1136/bmj.f2539.
-
48.
Chwastiak L, Tek C. Unchanging mortality gap for people with schizophrenia [editorial]. Lancet. 2009; 374:590–592.
-
49.
Crump C, Winkleby MA, Sundquest K, Sundquist J. Comorbidities and mortality in persons with schizophrenia. Am J Psychiatry. 2013; 170:324–333.
-
50.
Robinson DG. Early mortality among people with schizophrenia (editorial). Am J Psychiatry. 2016; 173:554.
-
51.
Tihonen J, Mittendorfer-Rutz E, Rotniainen M, et al. Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia. Am J Psychiatry. 2016; 173:600–606.
-
52.
Dalsgaard S, Ostergaard SD, Leckman JF, et al. Mortality in children, adolescents and adults with ADHD. Lancet. dx.doi.org/10.1016/S0140-6736(14)61684-6, 2015.
-
53.
Herttua K, Martikainen P, Vahtera J, et al. Living alone and alcohol-related mortality: a population-based cohort study from Finland. PLOS Medicine. 2011; 8:9, e1001094
-
54.
Kendler KS, Ohlsson H, Sundquist J, et al. Alcohol use disorder and mortality across the lifespan. JAMA Psychiatry. 2016; 73:575–581.
-
55.
Liskow BI, Powell BJ, Penick E, et al. Mortality in male alcoholics after 10-14 years. J Stud Alcohol. 2000; 61:853–861.
-
56.
Hser Y, Kagihara J, Huang D, et al. Mortality among substance-using mothers in California: a 10-year prospective study. Addiction. 2011. doi: 10.1111/j.1360-0443.2011.03613.x.
-
57.
Torralba L, Brugal MT, Villalbi JR. Mortality due to acute adverse drug reactions: opiates and cocaine in Barcelona. Addiction. 1996; 91:419–426.
-
58.
Baggett TP, Hwang SW, O'Connell JJ, et al. Mortality among homeless adults in Boston. JAMA Intern Med. 2013; 173:189–195.
-
59.
Cruts G, Buster M, Vicente J, et al. Estimating the total mortality among problem drug users. Substance Use and Misuse. 2008; 43:733–747.
-
60.
Walker ER, Pratt LA, Schoenborn CA, et al. Excess mortality among people who report lifetime use of illegal drugs in the US: a 20 year follow-up of a nationally representative survey. Drug Alcohol Dependence. 2017; 171:31–38.
-
61.
Callaghan RC, Gatley JM, Sykes J, et al. Prominence of smoking related mortality among individuals with alcohol or drug use disorders. Drug and Alcohol Review. doi: 10.1111/dar:12475 (2016).
-
62.
Walter F, Cart MJ, Mok PL. Premature mortality among patients recently discharged from their first inpatient psychiatric treatment. JAMA Psychiatry 74:485–492, 2017.
-
63.
Fok MLY, Hayes RD, Chang CK, et al. Life expectancy at birth and all cause mortality among people with personality disorder. J Psychosomatic Research. 2012; 73:104–107.
-
64.
Fok MLY, Stewart R, Hayes RD, et al. Predictors of natural and unnatural mortality among patients with personality disorder: evidence from a large UK case register. PLOS One. doi: 10.1371/journal.pone.0100979.
-
65.
Høye A1, Jacobsen BK, Hansen V. Sex differences in mortality of admitted patients with personality disorders in North Norway—a prospective register study. BMC Psychiatry. 2013; Nov 26;13:317. doi: 10.1186/1471-244X-13-317.
-
66.
Herbert A, Gilbert R, Gonzalez-Izquierdo A, et al. 10-y risks of death and emergency re-admission in adolescents hospitalised with violent, drug- or alcohol-related, or self-inflicted injury: a population-based cohort study. PLOS Med. 12(12): e1001931. doi: 10.1371/journal.pmed.1001931.
-
67.
Aaisma MC, Lau KSL, Perkins AJ, et al. Mortality of youth offenders along a continuum of justice system involvement. Am J Preven Med. 2016; 50:303–310.
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 2238 | 2163 | 36 |
| Full Text Views | 33 | 7 | 0 |
| PDF Downloads | 0 | 0 | 0 |
